Topic

Reversing Aging

Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions

1290 articles

AKG Metabolite Pathway Slows Stem Cell Aging via Newly Identified Protein Axis
Longevity & Aging

AKG Metabolite Pathway Slows Stem Cell Aging via Newly Identified Protein Axis

Scientists pinpoint the AKG-IDH1-RPS23 axis as a key regulator of stem cell senescence, opening new doors for anti-aging metabolic therapies.

Research Paper
May 14, 2026 0
Diabetes Fuels Pancreatic Cancer by Aging Blood Vessel Cells Prematurely
Longevity & Aging

Diabetes Fuels Pancreatic Cancer by Aging Blood Vessel Cells Prematurely

Senescent tumor endothelial cells secrete INHBB under diabetic conditions, accelerating pancreatic cancer—and blocking its receptor shows therapeutic promise.

Research Paper
May 14, 2026 0
CD4 T Cell Therapy Blocks Inflammaging by Protecting the Gut Barrier
Longevity & Aging

CD4 T Cell Therapy Blocks Inflammaging by Protecting the Gut Barrier

Restoring regulatory T cells prevents gut leakiness, dysbiosis, and systemic inflammation—extending healthspan in a mouse aging model.

Research Paper
May 14, 2026 0
Free Radicals & Your Cells: The Good, the Bad, and the Manageable
Longevity & Aging
Premium

Free Radicals & Your Cells: The Good, the Bad, and the Manageable

Discover what free radicals and reactive oxygen species actually are, why they're not purely villains, and how your body uses them as clever signals — with practical steps to keep the balance right for healthy aging.

TutorialBeginner
May 14, 2026 0
Lewy Body Dementia Is Far More Common Than Diagnoses Suggest
Longevity & Aging

Lewy Body Dementia Is Far More Common Than Diagnoses Suggest

A major meta-analysis reveals widespread underdiagnosis of Lewy body dementia, the second most common degenerative dementia after Alzheimer's.

Press Release
May 14, 2026 0
Two to Three Cups of Coffee Daily Linked to 35% Lower Dementia Risk in Major Study
Longevity & Aging

Two to Three Cups of Coffee Daily Linked to 35% Lower Dementia Risk in Major Study

A 43-year study of 131,000+ adults found moderate caffeine intake cuts dementia risk by 35% — but more isn't better.

Press Release
May 14, 2026 0
FDA Fast Track Granted for ALS Drug COYA 302 Targeting Immune Inflammation
Longevity & Aging

FDA Fast Track Granted for ALS Drug COYA 302 Targeting Immune Inflammation

COYA 302 combines low-dose IL-2 and CTLA-4 Ig to boost regulatory T cells and curb ALS-driving inflammation, now on an expedited FDA path.

Press Release
May 14, 2026 0
WHOOP Launches Telehealth Integration to Turn Wearable Data Into Clinical Action
Longevity & Aging

WHOOP Launches Telehealth Integration to Turn Wearable Data Into Clinical Action

WHOOP is adding in-app telehealth this summer, letting clinicians analyze your continuous biometric data alongside medical records and lab work.

Press Release
May 14, 2026 0
The Complete Guide to Cellular Aging Models and How to Reverse Them
Longevity & Aging

The Complete Guide to Cellular Aging Models and How to Reverse Them

A comprehensive review maps every major in vitro aging model—from Hayflick's fibroblasts to iPSCs—and the interventions that reverse cellular aging.

Research Paper
May 14, 2026 0
ISSN Updates HMB Position Stand With 12 Evidence-Based Recommendations
Longevity & Aging

ISSN Updates HMB Position Stand With 12 Evidence-Based Recommendations

The International Society of Sports Nutrition's comprehensive 2025 review affirms HMB's safety and multi-faceted benefits for muscle, performance, and aging.

Research Paper
May 13, 2026 0
Mushroom Antioxidant Ergothioneine Fights Hair Graying and Loss via SIRT1/Nrf2
Longevity & Aging

Mushroom Antioxidant Ergothioneine Fights Hair Graying and Loss via SIRT1/Nrf2

Ergothioneine, found in edible fungi, activates SIRT1/Nrf2 signaling in hair follicle cells to reduce oxidative damage and reverse aging-related hair loss.

Research Paper
May 13, 2026 0
GPX1 Gene Links Frailty and Hypertension With Two Natural Compounds as Targets
Longevity & Aging

GPX1 Gene Links Frailty and Hypertension With Two Natural Compounds as Targets

A Mendelian randomization study identifies GPX1 as a shared druggable target for frailty and hypertension, mediated by glycine and carnitine pathways.

Research Paper
May 13, 2026 0
PreviousPage 12 of 108Next